Stonebrook Private’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
5,476
-4,472
-45% -$361K 0.08% 143
2026
Q1
$862K Sell
9,948
-362
-4% -$34.7K 0.18% 85
2025
Q4
$990K Sell
10,310
-16,877
-62% -$1.64M 0.21% 76
2025
Q3
$2.59M Buy
27,187
+455
+2% +$41.8K 0.56% 47
2025
Q2
$2.33M Buy
26,732
+303
+1% +$25.7K 0.54% 49
2025
Q1
$2.37M Buy
26,429
+422
+2% +$37.8K 0.62% 48
2024
Q4
$2.08M Sell
26,007
-902
-3% -$78.1K 0.54% 47
2024
Q3
$2.42M Sell
26,909
-381
-1% -$32.1K 0.64% 44
2024
Q2
$2.15M Buy
27,290
+2,191
+9% +$180K 0.62% 45
2024
Q1
$2.19M Buy
25,099
+1,837
+8% +$157K 0.64% 42
2023
Q4
$1.92M Buy
+23,262
New +$1.77M 0.64% 41

Other funds holding MDT

Stonebrook Private's MDT Position: Q2 2026 in Review

Stonebrook Private reduced its Medtronic (MDT) stake by 45% in Q2 2026, selling an estimated $361K and leaving 5,476 shares worth $428K. The position accounts for 0.08% of the portfolio, ranked #143.

Stonebrook Private first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.59M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stonebrook Private held 5,476 shares of Medtronic worth $428K as of Q2 2026.
  • Stonebrook Private sold 4,472 Medtronic shares in Q2 2026, an estimated $361K.
  • Medtronic made up 0.08% of Stonebrook Private's portfolio in Q2 2026, its #143 holding.
  • Stonebrook Private first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Stonebrook Private's Medtronic position peaked at $2.59M in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.